Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,735,010
+$201,649 QoQ
Shares Held
227,127
-13.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#134
of 641 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $228,114,768 across 7 Biotechnology names. RPRX ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
234,624 | $116,544,779 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
82,164 | $51,232,540 | |
| 3 | INCY |
Incyte Corp
|
203,661 | $23,087,010 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
227,127 | $12,735,010 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
40,803 | $9,832,298 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
130,277 | $7,454,449 | |
| 7 | BNTX |
BioNTech SE
|
77,686 | $7,228,682 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,735,010 | 227,127 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,533,361 | 261,275 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,246,712 | 291,064 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $11,065,289 | 313,642 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,739,799 | 325,834 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,899,090 | 317,992 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $9,767,932 | 382,906 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $10,339,995 | 365,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,255,159 | 692,270 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,944,035 | 393,284 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,671,940 | 273,120 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,891,959 | 290,787 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,000,060 | 325,311 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,372,869 | 315,650 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,424,088 | 364,982 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,679,443 | 91,574 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,837,358 | 43,705 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $571,426 | 14,667 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $464,252 | 11,650 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $432,198 | 11,959 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $627,597 | 15,311 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $639,338 | 14,657 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||